Use of GIP and GLP-1 receptor agonists in prostate cancer patients.

Authors

• William Kelly

Publication/Presentation Date

5-2025

Volume

43

Issue

16

Published In/Presented At

DOI: 10.1200/JCO.2025.43.16_suppl.5024

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article